Академический Документы
Профессиональный Документы
Культура Документы
TechnicalCommunications
23October2003
Chapter11Ex.5
Aspirin
Itisestimatedthat80billionaspirintabletsperyearareconsumed.Aspirinislistedin
morethan50overthecounterdrugsinwhichaspirinislistedprincipleactiveingredient.
Afteracenturyofdevelopmentaspirinhasbecomethefocusofclinicaltrialsranging
fromcardiovasculardiseaseandcancertomigraineheadachesandhighbloodpressurein
pregnancy.Whatisitaboutthisdrugthat,atsmalldosesreducesfeverandeasesminor
achesandpains,andatcomparativelylargedosescombatspainandinflammationin
rheumatoidarthritisandseveralotherrelateddiseases?
Theanswerisnotfullyknown,butinthe1970s,aBritishpharmacologist,JohnVane,
Ph.D.,notedthatmanyformsoftissueinjurywerefollowedbythereleaseof
prostaglandins.Theseprostaglandinscauserednessandfever,commonsignsof
inflammation.Aspirincanalsopreventbloodplateletsfromaggregating.This
explanationofhowaspirinandothernonsteroidalantiinflammatorydrugs,prompted
laboratoryandclinicalscientisttoformandtestnewideasaboutaspirin.Interestwas
quicklyfocusedonlearningwhetheraspirinmightpreventthebloodclotsresponsiblefor
heartattacks.About1,250,000peoplesufferfromheartattackseachyearintheUnited
States,andsome500,000thousandofthemdieeachyear.
Couldaspirinhelp?
Tolearnwhetheraspirincouldbehelpful,scientisthascarriedoutnumerouslarge
randomizedcontrolledclinicalstudies.Inthesestudies,aspirinorplacebowasgivento
participants.Theinvestigatorsdidntknowwhichpersonreceivedtheaspirinorplacebo.
Thisallowedclearandtruthfulresults.Studieshaveshownthataspirinsubstantially
reducestheriskofdeathornonfatalheartattacksinpatientswithapreviousMIor
unstableanginapectoris,whichoftenoccursbeforeaheartattack.
AspirinforHealthyPeople?
Onceaspirinsbenefitsforpatientswithcardiovasculardiseasewereestablished,scientist
soughttolearnwhetherregularaspirinusewouldpreventafirstheartattackinhealthy
individuals.Therewere22,000malephysiciansbetween40and84withnopriorhistory
ofheartdiseasetested.Halftookoneaspirintableteveryotherday,andhalftook
placebo.Investigatorsfoundthatthegrouptakingaspirinhadasubstantialreductionin
therateoffatalandnonfatalheartattackscomparedwiththeplacebogroup.However,
therewasnosignificantdifferencebetweenthesegroups.
TheU.S.PreventiveServicesTaskForce,apanelofmedicalscientificauthoritiesin
healthpromotionanddiseaseprevention,recommendedthatlowdosesofaspirintherapy
shouldbeconsideredformenage40andoverwhoareatsignificantlyincreasedrisk
formmyocardialinfarctionandwholackcontraindicationstoaspirinuse.Avarietyof
possibleusesofaspirinare:preventingtheseverityofmigraineheadaches,improving
circulationtothegumstherebyarrestingperiodontaldisease,preventingcertaintypesof
cataracts,loweringtheriskofrecurrenceofcolorectalcancer,andcontrollingthe
dangerouslyhighbloodpressurethatoccursin5to15percentofpregnancies.Noneof
theseusesforaspirinhasshownconclusivelytobesafeandeffective.TheFDAproposed
newlabelingmethodsbecauseofthemisuseofaspirin.
TheOtherSideofTheCoin
Whileexaminingnewpossibilitiesforaspirinindiseasetreatmentandprevention,
scientistdonotlosesightofthefactthatevenatlowdosesaspirinisnotharmless.
Aspirinsantiplateletactivityapparentlyaccountsforhemorrhagicstrokes,causedby
bleedingintothebrain,inasmallbutsignificantpercentageofpersonswhousethedrug
regularly.Newunderstandingsofhowaspirinworksandwhatitcandoleavesnodoubt
thatthedrugahsafarbroaderrangeofusesthanimagined[nearlyacenturyago].Until
somecriticalverdictsarehandeddown,consumersarewelladvisedtoregardaspirin
withappropriatecaution.